|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
|
US5308348A
(en)
*
|
1992-02-18 |
1994-05-03 |
Alza Corporation |
Delivery devices with pulsatile effect
|
|
US5456679A
(en)
*
|
1992-02-18 |
1995-10-10 |
Alza Corporation |
Delivery devices with pulsatile effect
|
|
US5484607A
(en)
*
|
1993-10-13 |
1996-01-16 |
Horacek; H. Joseph |
Extended release clonidine formulation
|
|
US5540665A
(en)
*
|
1994-01-31 |
1996-07-30 |
Alza Corporation |
Gas driven dispensing device and gas generating engine therefor
|
|
US5505952A
(en)
*
|
1994-04-19 |
1996-04-09 |
United States Surgical Corporation |
Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom
|
|
NZ288144A
(en)
*
|
1994-06-22 |
1998-12-23 |
Unasco Pty |
Active agent sustained release capsule: fluid expandable layers and active agent layers
|
|
US5595752A
(en)
*
|
1994-07-01 |
1997-01-21 |
Monsanto Company |
Increasing dressing percentage and carcass weight in finishing beef cattle
|
|
US5672357A
(en)
*
|
1994-07-01 |
1997-09-30 |
Monsanto Company |
Method and device for implantation of large diameter objects in bovines
|
|
US5743879A
(en)
*
|
1994-12-02 |
1998-04-28 |
Science Incorporated |
Medicament dispenser
|
|
US5788673A
(en)
*
|
1995-06-05 |
1998-08-04 |
Atrion Medical Products, Inc. |
Drug infusion system
|
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
|
US6395292B2
(en)
*
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
US6132420A
(en)
*
|
1996-02-02 |
2000-10-17 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
|
AU739469B2
(en)
*
|
1996-12-20 |
2001-10-11 |
Alza Corporation |
Gel composition and methods
|
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
US6994851B1
(en)
|
1997-07-10 |
2006-02-07 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
MY125849A
(en)
*
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
|
|
US6551613B1
(en)
*
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
|
US20030170181A1
(en)
*
|
1999-04-06 |
2003-09-11 |
Midha Kamal K. |
Method for preventing abuse of methylphenidate
|
|
JP2002541092A
(ja)
|
1999-04-06 |
2002-12-03 |
ファーマクエスト・リミテッド |
メチルフェニデートのパルス性送達のための薬学的投薬形態
|
|
US6669954B2
(en)
|
2000-01-25 |
2003-12-30 |
John R. Crison |
Controlled release of drugs
|
|
US20030211974A1
(en)
*
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
|
US6582418B1
(en)
*
|
2000-06-01 |
2003-06-24 |
Medtronic, Inc. |
Drug pump with reinforcing grooves
|
|
US6500457B1
(en)
|
2000-08-14 |
2002-12-31 |
Peirce Management, Llc |
Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
|
|
BRPI0206432A2
(pt)
*
|
2001-01-12 |
2016-10-25 |
Sun Pharmaceutical Ind Ltd |
métodos para administrar dois ou mais agentes terapêuticos ativos e para tratar diabetes melito ou sintomas associados com diabetes melito em um humano e sistema de liberação espaçada de medicamento
|
|
DK1377276T3
(da)
*
|
2001-04-10 |
2012-01-02 |
Sun Pharma Advanced Res Co Ltd |
Beregning af puls-frigivelsessammensætning
|
|
CN1592610A
(zh)
*
|
2001-09-28 |
2005-03-09 |
麦克内尔-Ppc股份有限公司 |
改良的释放剂型
|
|
KR20040058101A
(ko)
*
|
2001-11-14 |
2004-07-03 |
알자 코포레이션 |
카테터 주입가능한 데포 조성물 및 그의 용도
|
|
US20070196415A1
(en)
*
|
2002-11-14 |
2007-08-23 |
Guohua Chen |
Depot compositions with multiple drug release rate controls and uses thereof
|
|
KR20040065153A
(ko)
*
|
2001-11-14 |
2004-07-21 |
알자 코포레이션 |
주입가능한 데포 조성물
|
|
JP5078217B2
(ja)
*
|
2001-11-14 |
2012-11-21 |
デュレクト コーポレーション |
注入可能なデポー組成物およびそれらの使用
|
|
CN1668279A
(zh)
*
|
2002-06-17 |
2005-09-14 |
阿尔萨公司 |
具有包含分散在液体载体中的渗透物质的早期零级推动力动力系统的渗透递送体系
|
|
AR039729A1
(es)
|
2002-06-25 |
2005-03-09 |
Alza Corp |
Formulaciones de deposito de corta duracion
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
EP1551493B1
(en)
*
|
2002-06-26 |
2007-10-31 |
Alza Corporation |
Minimally compliant, volume efficient piston for osmotic drug delivery systems
|
|
NZ537953A
(en)
|
2002-07-31 |
2007-02-23 |
Alza Corp |
Injectable multimodal polymer depot compositions and uses thereof
|
|
US8252303B2
(en)
*
|
2002-07-31 |
2012-08-28 |
Durect Corporation |
Injectable depot compositions and uses thereof
|
|
JP2006508127A
(ja)
*
|
2002-11-06 |
2006-03-09 |
アルザ・コーポレーション |
制御された放出性デポー剤配合物
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
WO2004108067A2
(en)
*
|
2003-04-03 |
2004-12-16 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
|
EP1643968A1
(en)
*
|
2003-05-30 |
2006-04-12 |
ALZA Corporation |
Implantable elastomeric depot compositions, uses thereof and method of manufacturing
|
|
US20070184084A1
(en)
*
|
2003-05-30 |
2007-08-09 |
Guohua Chen |
Implantable elastomeric caprolactone depot compositions and uses thereof
|
|
US20060142234A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
|
AU2005321940B2
(en)
*
|
2004-12-29 |
2012-04-19 |
Mannkind Corporation |
Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US8022054B2
(en)
|
2005-11-28 |
2011-09-20 |
Marinus Pharmaceuticals |
Liquid ganaxolone formulations and methods for the making and use thereof
|
|
US20070163968A1
(en)
*
|
2006-01-17 |
2007-07-19 |
Johnsondiversey, Inc. |
Method and apparatus for providing treatment chemicals to process water systems
|
|
US20090069275A1
(en)
*
|
2006-02-17 |
2009-03-12 |
Rocca Jose G |
Low flush niacin formulation
|
|
CN101453982B
(zh)
|
2006-05-30 |
2011-05-04 |
精达制药公司 |
两件式内部通道渗透递送系统流动调节器
|
|
NZ593017A
(en)
|
2006-08-09 |
2011-08-26 |
Intarcia Therapeutics Inc |
Piston assembly for positioning lumen in an osmotic delivery system having groove to retain elastomeric O-ring
|
|
JP2010510988A
(ja)
|
2006-11-28 |
2010-04-08 |
マリナス ファーマシューティカルズ |
ナノ粒子製剤とその製造方法およびその利用
|
|
RU2440097C2
(ru)
|
2007-04-23 |
2012-01-20 |
Интарсия Терапьютикс, Инк. |
Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
|
|
US20100172991A1
(en)
*
|
2007-06-08 |
2010-07-08 |
Henry Joseph Horacek |
Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
|
|
JP2010529142A
(ja)
*
|
2007-06-08 |
2010-08-26 |
アドレネクス・ファーマシューティカルズ,インコーポレイテッド |
アドレナリン調節異常症を治療する徐放性の製剤および方法
|
|
WO2009102467A2
(en)
|
2008-02-13 |
2009-08-20 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
US20100076370A1
(en)
|
2008-09-23 |
2010-03-25 |
Infusion Advancements, LLC. |
Apparatus and methods for purging catheter systems
|
|
WO2011014078A1
(en)
|
2009-07-31 |
2011-02-03 |
Ancare Scientific Limited |
Sustained release capsules
|
|
SMT201700583T1
(it)
|
2009-09-28 |
2018-01-11 |
Intarcia Therapeutics Inc |
Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario
|
|
US8679093B2
(en)
|
2010-11-23 |
2014-03-25 |
Microchips, Inc. |
Multi-dose drug delivery device and method
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
JP6564369B2
(ja)
|
2013-12-09 |
2019-08-21 |
デュレクト コーポレイション |
薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
JP6993235B2
(ja)
|
2015-06-03 |
2022-01-13 |
インターシア セラピューティクス,インコーポレイティド |
インプラントの設置及び撤去システム
|
|
EP3733694A1
(en)
|
2016-05-16 |
2020-11-04 |
Intarcia Therapeutics, Inc |
Glucagon-receptor selective polypeptides and methods of use thereof
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
BR112019002538A2
(pt)
|
2016-08-11 |
2019-05-21 |
Ovid Therapeutics Inc. |
uso de uma composição farmacêutica compreendendo um modulador alostérico, uso de uma composição farmacêutica compreendendo garboxadol ou um sal farmaceuticamente aceitável do mesmo, e composição farmacêutica para a administração parenteral
|
|
JP7286542B2
(ja)
|
2017-01-03 |
2023-06-05 |
インターシア セラピューティクス,インコーポレイティド |
Glp-1受容体アゴニストの持続的投与及び薬物の同時投与を含む方法
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
US11266662B2
(en)
|
2018-12-07 |
2022-03-08 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of postpartum depression
|
|
CN109589491B
(zh)
*
|
2019-01-29 |
2024-01-09 |
上海安翰医疗技术有限公司 |
自动给药装置
|
|
CA3145923A1
(en)
|
2019-08-05 |
2021-02-11 |
David Czekai |
Ganaxolone for use in treatment of status epilepticus
|
|
JP7780431B2
(ja)
|
2019-12-06 |
2025-12-04 |
マリナス ファーマシューティカルズ, インコーポレイテッド |
結節性硬化症の治療での使用のためのガナキソロン
|
|
JP2023515918A
(ja)
|
2020-01-13 |
2023-04-17 |
デュレクト コーポレーション |
不純物が低減された徐放性薬物送達システム及び関連の方法
|
|
JP2024503402A
(ja)
|
2021-01-12 |
2024-01-25 |
デュレクト コーポレーション |
徐放性薬物送達システム及び関連の方法
|
|
WO2025147450A1
(en)
*
|
2024-01-02 |
2025-07-10 |
Manta Pharma Llc |
Implantable device for adjustable dose using pressure sensor for piston displacement monitoring
|
|
US12390581B1
(en)
*
|
2024-12-31 |
2025-08-19 |
MantaMedTech LLC |
Active implantable medical device (AIMD) system for drug delivery with fixed dose size
|
|
US20250339607A1
(en)
*
|
2024-01-02 |
2025-11-06 |
Manta MedTech LLC |
Wearable device having piston displacement monitoring
|
|
US20250339609A1
(en)
*
|
2024-01-02 |
2025-11-06 |
Manta MedTech LLC |
System for drug delivery with fixed dose size
|
|
EP4684816A1
(en)
*
|
2024-07-23 |
2026-01-28 |
Manta MedTech LLC |
Implantable device for adjustable dose using pressure sensor for piston displacement monitoring
|